Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Classification & Labelling & PBT assessment

PBT assessment

Currently viewing:

Administrative data

PBT assessment: overall result

Referenceopen allclose all

Name:
1,4-naphthoquinone
Type of composition:
boundary composition of the substance
State / form:
solid: particulate/powder
Reference substance:
1,4-naphthoquinone
Name:
1,4-naphthoquinone
Type of composition:
legal entity composition of the substance
State / form:
solid: particulate/powder
Reference substance:
1,4-naphthoquinone
PBT status:
the substance is not PBT / vPvB
Justification:

Comparison with the Criteria of Annex XIII. An assessment of the PBT/vPvB status of the test substance has been made using all available data.

Persistence Assessment. The substance is not considered to be readily biodegradable with no biodegradation seen in a 28 day study. However, hydrolysis of the substance was observed with an experimental half-life at 25°C of 12 days at neutral pH. This half-life was greatly reduced under alkaline conditions. This indicates that the substance is unlikely to be persistent under environmental conditions and will likely degrade abiotically.

Bioaccumulation Assessment: No studies to assess bioaccumulation in aquatic species have been conducted. The low Log Kow value (<4.5) indicates that the test material is unlikely to be bioaccumulative in aquatic systems, and as such is considered to have a low potential for bioaccumulation.

Toxicity assessment: The acute toxicity for all three trophic levels are much higher than the PBT screening criterion of < 0.1 mg/L (Fish the most sensitive species with a 96hr LC50 of 33.5 mg/L).

The overall conclusions, based on the present available data, are that the (screening) criteria for PBT/vPvB, as outlined in Annex XIII of REACH, are not met and that further testing in the scope of the final PBT assessment is not considered to be required.